On behalf of Biointelect, we are delighted to welcome you to Australia’s 2nd Vaccine Value Chain Conference 2026 in Sydney.

Building on the strong foundations of AVVCC24, this conference brings together leaders from government, industry, academia, research, investment and the broader immunisation community to strengthen collaboration across the end to end vaccine value chain. At a time of rapid geopolitical change, evolving policy reform and renewed focus on national health resilience, it is more important than ever to align our collective efforts to reinforce the value of vaccines and infectious disease control.

AVVCC26 provides a vital platform to enhance public private partnerships, share knowledge, shape practical recommendations and support Australia’s ambition to remain a globally relevant and competitive contributor to the vaccine ecosystem. We look forward to fostering meaningful dialogue, enabling new collaborations and driving tangible outcomes that will strengthen health impact and innovation across the nation.